- Visibility 259 Views
- Downloads 234 Downloads
- Permissions
- DOI 10.18231/j.ijced.80292.1758877439
-
CrossMark
Efficacy of minoxidil in patients of patterned hair loss: A prospective study at a tertiary care hospital of Central India
- Author Details:
-
Kashish Sindhwani *
-
Anjali Kushwah
-
Babita Sheoran
-
Prabhjot Kaur
-
Abhishek Madhu Paserkar
Prabhjot Kaur
Abhishek Madhu Paserkar
Introduction: Androgenetic alopecia (AGA), commonly referred to as "male-pattern baldness" or "female-pattern hair loss," is a genetically determined condition characterized by an excessive sensitivity to androgens. Common methods for diagnosing hair disorders include clinical examination, assessment of hair loss patterns, pull test, trichogram, biopsy, and screening blood tests. Currently, trichoscopy is the most important diagnostic method for androgenetic alopecia (AGA) and has largely replaced scalp biopsies. There is a notable gap in research on the early effects of minoxidil therapy as observed through trichoscopy. This gap offers a unique opportunity for further investigation.
Materials and Methods: A prospective cohort study was conducted for one year at the department of pharmacology and department of dermatology, M.G.M Medical College, Indore, after approval by the institutional ethics committee. The study included patients presenting with hair loss and thinning. The treatment used was topical minoxidil. The study was conducted on 50 patients diagnosed with patterned hair loss, who met the inclusion and exclusion criteria.
Results: We aimed to assess efficacy of minoxidil therapy in patients diagnosed with patterned hair loss using trichoscopy. A total of 100 patients were enrolled, with 50 patients (Group M) receiving minoxidil alone—5% solution for males and 2% solution for females. The mean age of the minoxidil group was 33.58 ± 6.57 years. Our results showed significant improvements in several trichoscopic parameters, including an increase in vellus-like hairs, reduced anisotrichosis, the appearance of peripilar signs, yellow dots, and the presence of single-hair follicular units—indicating positive early responses to minoxidil therapy.
Conclusion: Minoxidil is an effective drug for the treatment ofpatterned hair loss, both in male and female patients as assessed by five different parameters using trichoscopy.
References
- Ho CH, Sood T, Zito PM. Androgenetic Alopecia. [Updated 2021 Nov 15]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022.
- Blume-Peytavi U, Blumeyer A, Tosti A, Finner A, Marmol V, Trakatelli M, et al. European Consensus Group. S1 guideline for diagnostic evaluation in androgenetic alopecia in men, women and adolescents. Br J Dermatol. 2011;164(1):5–15.
- Paik JH, Yoon JB, Sim WY, Kim BS, Kim NI. The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol. 2001;145(1):95–9.
- Tosti A, Piraccini BM. Androgenetic alopecia. Int J Dermatol. 1999;38 Suppl 1:1–7.
- Krupa Shankar D, Chakravarthi M, Shilpakar R. Male androgenetic alopecia: population-based study in 1,005 subjects. Int J Trichology. 2009;1(2):131–3.
- Cranwell W, Sinclair R. Male Androgenetic Alopecia. 2016 Feb 29. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, et al, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2000
- Rathnayake D, Sinclair R. Male androgenetic alopecia. Expert Opin Pharmacotherapy. 2010;11(8):1295–304.
- Gan DC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. J Investig Dermatol Symp Proc. 2005;10(3):184–9.
- Olsen EA, Messenger AG, Shapiro J, Bergfeld WF, Hordinsky MK, Roberts JL, et al. Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol. 2005;52(2):301–11.
- Otberg N, Finner AM, Shapiro J. Androgenetic alopecia. Endocrinol Metab Clin North Am. 2007;36(2):379–98.
- Mahmoudi H, Salehi M, Moghadas S, Ghandi N, Teimourpour A, Daneshpazhooh M. Dermoscopic Findings in 126 Patients with Alopecia Areata: A Cross -Sectional Study. Int J Trichology. 2018;10(3):118–23.
- Kasumagic-Halilovic E. Trichoscopic Findings in Androgenetic Alopecia. Med Arch. 2021;75(2):109–11.
- Tosti A, Torres F. Dermoscopy in the diagnosis of hair and scalp disorders. Actas Dermosifiliogr, 2009:100(1):114–9.
- Alessandrini A, Starace M, D’Ovidio R, Villa L, Rossi A, Stan TR, et al. Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines. G Ital Dermatol Venereol. 2020;155(5):622–31
- Campese VM. Minoxidil: a review of its pharmacological properties and therapeutic use. Drugs. 1981;22(4):257–78.
- Rossi A, Cantisani C, Melis L, Iorio A, Scali E, Calvieri S. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130–6.
- Gogtay JA, Panda M. Minoxidil topical foam: a new kid on the block. Int J Trichology. 2009;1(2):142.
- Purnak T, Senel E, Sahin C. Liquid formulation of minoxidil versus its foam formulation. Indian J Dermatol. 2011;56(4):462.
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777–86.
- Lowenthal DT, Affrime MB. Pharmacology and pharmacokinetics of minoxidil. J Cardiovasc Pharmacol. 1980;2(Suppl 2):S93–S106.
- Pedrosa AF, Morais P, Lisboa C, Azevedo F. The importance of trichoscopy in clinical practice. Dermatol Res Pract. 2013:986970.
- Azam MH, Morsi HM. Comparative Study Between 2% Minoxidil Topical Spray vs. Intradermal Injection (Mesotherapy) for Treatment of Androgenetic Alopecia in Female Patients: A Controlled, 4-month Randomized Trial. Medicine. 2010.
- Mansuri UU, Vaaruni R, Parmar KS, Shah BJ. A comparative study of treatment modalities in female androgenetic alopecia. Int J Res Med Sci. 2016;4:1229–36.
- Rajput RJ. Controlled clinical trial for evaluation of hair growth with low dose cyclical nutrition therapy in men and women without the use of finasteride. Plast Aesthet Res. 2017;4:161–73.
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019;13:2777–86. doi: 10.2147/DDDT.S214907
[Google Scholar] Erratum in: Drug Des Devel Ther. 2020 ;14:575. - Karaca N, Akpolat ND (2019) A Comparative Study between Topical 5% Minoxidil and Topical “Redensyl, Capixyl, and Procapil” Combination in Men with Androgenetic Alopecia. J Cosmo Trichol. 2019;5:1. Sindhwani et al. / IP Indian Journal of Clinical and Experimental Dermatology 2025;11(3):388-393 393
- Marotta JC, Patel G, Carvalho M, Blakeney S. Clinical Efficacy of a Topical Compounded Formulation in Male Androgenetic Alopecia: Minoxidil 10%, Finasteride 0.1%, Biotin 0.2%, and Caffeine Citrate 0.05% Hydroalcoholic Solution. Int J Pharm Compd. 2020;24(1):69–76.
- Nestor MS, Ablon G, Gade A, Han H, Fischer DL. Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics. J Cosmet Dermatol. 2021;20(12):3759–81.
- Gowda A, Sankey SM, Sharath KBC. Comparative study of efficacy of minoxidil versus minoxidil with platelet rich plasma versus minoxidil with dermaroller in androgenetic alopecia. Int J Res Dermatol. 2021;7(2):279–84.
- Shetty VH, Goel S. Dermoscopic pre-and posttreatment evaluation in patients with androgenetic alopecia on platelet-rich plasma—A prospective study. J Cosmet Dermatol. 2019;18(5):1380–8.
- Han JH, Kwon OS, Chung JH, Cho KH, Eun HC, Kim KH. Effect of minoxidil on proliferation and apoptosis in dermal papilla cells of human hair follicle. J Dermatol Sci. 2004;34(2):91–8.
- Dhurat R, Saraogi P. Hair evaluation methods: Merits and demerits. Int J Trichology. 2009;1(2):108–19.
- El-Garf A, Salah E, Ahmed MM. The Use of Trichoscopy to Assess the Efficacy of Topical Minoxidil 2% Solution in Patients with Female Pattern Hair Loss. Zagazig Univ Med J. 2019;25(5):782–9.
- Gajjar PC, Mehta HH, Barvaliya M, Sonagra B. Comparative study between mesotherapy and topical 5% minoxidil by dermoscopic evaluation for androgenic alopecia in male – A randomised controlled trial. Int J Trichol .2019; 11:58-67